What You Should Know:
- Circular Genomics, a pioneer in unlocking the secrets of circular RNA (circRNA) for precision psychiatry and neurology, has secured $8.3 million in a Series A funding round. Led by Mountain Group Partners, this vital investment brings on board new partner UNM Rainforest Innovations and bolsters support from existing investors like Cottonwood Technology Fund and Tramway Venture Partners.
- The new funding will empower Circular Genomics to build and scale commercial
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Physician Burnout and Depression Rates Decline, Medscape Report Reveals
What You Should Know:
- For the first time in years, a glimmer of hope has emerged in the fight against physician burnout and depression.
- The latest Medscape Physician Burnout & Depression Report reveals a significant decline in the rates among U.S. doctors, suggesting a potential shift in the overall mental well-being of this critical workforce.
Burnout Rates Dip, but Challenges Remain
The Medscape Physician Burnout & Depression Report 2024, titled "We Have
Read More
Democratizing AI: NSF Launches AI Pilot for National Research Resource
What You Should Know:
The U.S. National Science Foundation (NSF), alongside a diverse coalition of government agencies, industry leaders, and non-profit organizations, has launched the National Artificial Intelligence Research Resource (NAIRR) pilot.
The NAIRR pilot marks a significant step towards a future where AI benefits everyone. By democratizing access to critical resources, fostering collaboration, and prioritizing responsible development, the NAIRR has the potential to unlock
Read More
Deliberate AI Joins FDA Pilot to Develop Mental Health Treatments
What You Should Know:
- Deliberate AI, a digital health company harnessing AI to revolutionize mental health assessment, has secured a major milestone in its mission. The U.S. Food and Drug Administration (FDA) has selected Deliberate AI's AI-generated Clinical Outcome Assessment (AI-COA™) for its Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program.
- The collaboration between Deliberate AI and the FDA represents a giant leap in the fight against mental
Read More
Isaac Health Secures $5.7M to Combat Dementia Deserts & Revolutionize Brain Care
What You Should Know:
- Isaac Health, a rising leader in digital brain health, has successfully closed an oversubscribed $5.7 million Seed funding round led by Meridian Street Capital and B Capital, bringing together prominent players like Primetime Partners, Co-Found Partners, VU Venture Partners, and AirAngels.
- This crucial funding round empowers Isaac Health to accelerate their mission by expanding their innovative brain health provider platform. advancing technology for improved
Read More
Health2047-Backed HEAL Security Emerges from Stealth with $4.6M
What You Should Know:
- Health2047, the American Medical Association's venture studio dedicated to healthcare innovation, announced its investment in and launch from stealth of HEAL Security, a cognitive cybersecurity platform built specifically for the healthcare industry.
- Health2047's investment in HEAL Security underscores the urgent need for robust and specialized cybersecurity solutions within the healthcare industry. Their platform equips health systems with the necessary tools to
Read More
Being Health Unveils $5.4M-Backed Modern Mental Health Practice in Lower Manhattan
What You Should Know:
Being Health, a psychiatrist-founded modern mental health practice, launches today to bring the best of psychiatry, psychotherapy, novel treatments (such as ketamine infusion therapy), functional medicine and wellness services (such as acupuncture and nutrition) all under one roof for a seamless patient experience in New York City.Being Health has raised $5.4 million to date in funding from 18 Park and HDS Capital.
Personalising Access to Mental Health
Read More
Culmination Bio and Merck Announce R&D Collaboration in Autoimmune Disease Research
What You Should Know:
Culmination Bio, a data and technology company combining clinical and biospecimen data, announced an R&D collaboration with Merck, known as MSD, outside the United States and Canada, initially in the area of autoimmune disease.Under the terms of the master agreement, Merck will have access to both clinical (Electronic Health Records, labs, medications) and paired biospecimen (tissue and blood) data from several cohorts of various sizes and qualifications. This
Read More
Maven Clinic Partners with WellTheory to Offer Employees Autoimmune Care
What You Should Know:
WellTheory, a first-of-its-kind virtual solution for the 50 million Americans suffering with autoimmune disease, today announced its first employer partnership with Maven Clinic, the world's largest virtual clinic for women's and family health.Beginning today, Maven Clinic employees now have free access to WellTheory’s platform that offers evidence-based nutrition and lifestyle coaching to reduce autoimmune symptoms.
WellTheory's Holistic Program for Autoimmune
Read More
Unlocking Patient Insights with Conversational AI in Healthcare
Healthcare leaders should champion human-AI collaboration by having people work with AI to validate insights and develop engagement strategies. Organizations can — and should — implement conversational AI because it allows leaders to identify actionable areas of change and protects individuals’ privacy and identities.
Yet while these organizations recognize the merit of sharing these conversations enterprise-wide, many worry that doing so will compromise data privacy and compliance. But
Read More
